Since these two fusion proteins have structurally similar domains, would MEF2C::SS18L1-positive B-ALL patients have similar clinical, pathological, or genetic features as MEF2D::SS18 positive patients? The gene discussed is SS18L1; the disease is precursor B-cell acute lymphoblastic leukemia.